Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS) "SENTIS"


Phase 3 Results N/A



  • Shuaib A, Bornstein NM, Diener HC, Dillon W, Fisher M, Hammer MD, Molina CA, Rutledge JN, Saver JL, Schellinger PD, Shownkeen H; for the SENTIS Trial Investigators. Partial Aortic Occlusion for Cerebral Perfusion Augmentation: Safety and Efficacy of NeuroFlo in Acute Ischemic Stroke Trial. Stroke. 2011 May 12; [Epub ahead of print] Pubmed ID:21566232

Related Links

Sources for Trial Information